Debiopharm Innovation Fund SA and Tesi
Investor profile
Debiopharm Innovation Fund SA and Tesi has backed 1 European tech company across 1 funding round in 2018, joining rounds totalling €4.4M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2018
1 yr
Total round €
€4.4M
sum of rounds joined
Deals by year
distinct rounds / yearDebiopharm Innovation Fund SA and Tesi — deals by year — interactive chart.
Data table
| Debiopharm Innovation Fund SA and Tesi — deals by year | |
|---|---|
| 2018 | 1 |
Top sectors
by dealsDebiopharm Innovation Fund SA and Tesi — top sectors — interactive chart.
Data table
| Debiopharm Innovation Fund SA and Tesi — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsDebiopharm Innovation Fund SA and Tesi — stages — interactive chart.
Data table
| Debiopharm Innovation Fund SA and Tesi — stages | |
|---|---|
| Series A | 1 |
Countries
by dealsDebiopharm Innovation Fund SA and Tesi — countries — interactive chart.
Data table
| Debiopharm Innovation Fund SA and Tesi — countries | |
|---|---|
| Finland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Kaiku Health | Finland | 1 | €4.4M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Kaiku Health | Series A | €4.4M | 2018-02 |